SCHEMBL2581812

SCHEMBL2581812

C=C(C)C(=O)NC(C(=O)OCC)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.44
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
ALDH1A1 P00352 5/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.37
CAD P27708 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
KMT2A Q03164 2/20 0.34
POLB P06746 1/20 0.34
ALOX15 P16050 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12160531 0.92 TGFBR1 (0.42) TGFBR1MGAMGAASIMGAM2
SCHEMBL5490987 0.82 TGFBR1 (0.43) TGFBR1MGAMGAASIMGAM2
SCHEMBL12160526 0.81 EGLN1 (0.38) TGFBR1MGAMGAASIMGAM2
Methacrylic Acid SCHEMBL27674399 0.81 LMNA (0.46) TGFBR1MGAMGAASIMGAM2
SCHEMBL1332017 0.79 LMNA (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL81193 0.79 LMNA (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL1330728 0.79 LMNA (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL1332187 0.79 LMNA (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL1331748 0.79 LMNA (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL3787404 0.77 LMNA (0.51) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011146408-A1 HPMA POLYMER PLATINUM CHELATES ACCESS PHARMACEUTICALS, INC. (US) 2011-11-24 WO disclosed
WO-2011146408-A1 HPMA POLYMER PLATINUM CHELATES ACCESS PHARMACEUTICALS, INC. (US) 2011-11-24 WO disclosed
US-20110286958-A1 HPMA POLYMER PLATINUM CHELATES ACCESS PHARMACEUTICALS, INC. 2011-11-24 US disclosed
US-7754684-B2 Macromolecular platinum chelates ACCESS PHARMACEUTICALS, INC. (US) 2010-07-13 US disclosed
US-7754684-B2 Macromolecular platinum chelates ACCESS PHARMACEUTICALS, INC. (US) 2010-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110286958-A1 HPMA POLYMER PLATINUM CHELATES SLC46A1, PBRM1, SLC40A1 TGFBR1 2782/4885MGAM 1930/4885GAA 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.